JP2000333673A5 - - Google Patents

Download PDF

Info

Publication number
JP2000333673A5
JP2000333673A5 JP1999151599A JP15159999A JP2000333673A5 JP 2000333673 A5 JP2000333673 A5 JP 2000333673A5 JP 1999151599 A JP1999151599 A JP 1999151599A JP 15159999 A JP15159999 A JP 15159999A JP 2000333673 A5 JP2000333673 A5 JP 2000333673A5
Authority
JP
Japan
Prior art keywords
free protein
protein synthesis
continuous cell
synthesis method
energy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1999151599A
Other languages
Japanese (ja)
Other versions
JP2000333673A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP11151599A priority Critical patent/JP2000333673A/en
Priority claimed from JP11151599A external-priority patent/JP2000333673A/en
Priority to PCT/JP1999/004088 priority patent/WO2000068412A1/en
Priority to DE69940525T priority patent/DE69940525D1/en
Priority to AT99933168T priority patent/ATE424467T1/en
Priority to KR1020017014336A priority patent/KR100546009B1/en
Priority to EP99933168A priority patent/EP1176210B1/en
Priority to US10/019,995 priority patent/US6905843B1/en
Priority to EA200101189A priority patent/EA006162B1/en
Priority to AU49301/99A priority patent/AU765632B2/en
Priority to CA002373057A priority patent/CA2373057A1/en
Publication of JP2000333673A publication Critical patent/JP2000333673A/en
Priority to US11/089,652 priority patent/US7235382B2/en
Publication of JP2000333673A5 publication Critical patent/JP2000333673A5/ja
Pending legal-status Critical Current

Links

Description

【特許請求の範囲】
【請求項1】
胚芽抽出物を用いた無細胞タンパク質合成方法において、(1)合成反応の鋳型となるmRNAについて追加・保存・交換・排出から選択される処置を導入すること及び(2)エネルギー再生系酵素について追加・保存・交換・排出から選択される処置を導入することを特徴とする連続無細胞タンパク質合成方法。
【請求項2】
さらに基質又はエネルギー源について追加・保存・交換・排出から選択される処置を導入することを特徴とする請求項1に記載の連続無細胞タンパク質合成方法。
【請求項3】
胚芽抽出物が、胚乳局在性のトリチン、チオニン及びリボヌクレアーゼを完全に排除されていることを特徴とする請求項1又は2に記載の連続無細胞タンパク質合成方法。
【請求項4】
合成反応の鋳型となるmRNAを、原料として添加したmRNAの鋳型活性が低下傾向を示す前後に追加添加することを特徴とする請求項1〜3のいずれか1に記載の連続無細胞タンパク質合成方法。
【請求項5】
エネルギー再生系酵素を、原料として添加したエネルギー再生系酵素活性が低下傾向を示す前後に追加添加することを特徴とする請求項1〜4のいずれか1に記載の連続無細胞タンパク質合成方法。
【請求項6】
エネルギー再生系酵素がクレアチンキナ−ゼである、請求項1〜5のいずれか1に記載の連続無細胞タンパク質合成方法。
【請求項7】
mRNAの追加添加量が、原料mRNA量の10分の1から同量である請求項1〜6のいずれか1に記載の連続無細胞タンパク質合成方法。
【請求項8】
エネルギー再生系酵素の追加添加量が、原料エネルギー再生系酵素量の10分の1から同量である請求項1〜7のいずれか1に記載の連続無細胞タンパク質合成方法。
【請求項9】
mRNAの追加添加及びエネルギー再生系酵素の追加添加が、継続的に行われる請求項1〜8のいずれか1に記載の連続無細胞タンパク質合成方法。
【請求項10】
基質、エネルギー源が、枯渇することを防ぐ工程及び/又は副生成物を排出する工程を導入した請求項1〜9のいずれか1に記載の連続無細胞タンパク質合成方法。
【請求項11】
前記工程が透析外液の交換である請求項10に記載の連続無細胞タンパク質合成方法。
【請求項12】
追加・保存・交換・排出から選択される処置が自動制御された請求項1〜11のいずれか1に記載の連続無細胞タンパク質合成方法。
【請求項13】
請求項1〜12のいずれか1に記載の連続無細胞タンパク質合成方法を実行可能な連続無細胞タンパク質合成装置。
【請求項14】
請求項1〜12のいずれか1に記載の連続無細胞タンパク質合成方法に用いる試薬キット。
【請求項15】
合成反応の鋳型となるmRNA、エネルギー再生系酵素、基質、エネルギー源から選ばれる要素について追加・保存・交換・排出から選択される処置を導入可能な連続無細胞タンパク質合成装置であって、含浸槽とこれに密封可能に装着される蓋部とを含む構成からなり、該装置に基質及び/又はエネルギー源の導入手段である入口と透析外液の含浸槽内の液室につながる出口をもつ流路、透析外液中の代謝産物等の排出手段である含浸槽内の液室に存する入口と外部につながる出口をもつ流路、mRNA及び/又はエネルギー再生系酵素の導入手段である入口と透析外液の含浸槽内の液室に存する透析膜の機能を有する媒体を担持する装置。
[Claims]
(1)
In a cell-free protein synthesis method using an embryo extract, (1) introduction of a treatment selected from addition, storage, exchange, and discharge of mRNA serving as a template for a synthesis reaction, and (2) addition of an energy regeneration enzyme -A continuous cell-free protein synthesis method characterized by introducing a treatment selected from storage, exchange, and elimination.
(2)
2. The continuous cell-free protein synthesis method according to claim 1, further comprising introducing a treatment selected from addition, storage, exchange, and discharge of the substrate or energy source.
(3)
The continuous cell-free protein synthesis method according to claim 1 or 2, wherein the embryo extract is completely free of tristin, thionin and ribonuclease localized in endosperm.
(4)
The continuous cell-free protein synthesis method according to any one of claims 1 to 3, wherein an mRNA serving as a template for the synthesis reaction is additionally added before and after the template activity of the mRNA added as a raw material shows a tendency to decrease. .
Claim 5.
The method for synthesizing a continuous cell-free protein according to any one of claims 1 to 4, wherein the energy-regenerating system enzyme is added before and after the activity of the energy-regenerating system enzyme added as a raw material shows a tendency to decrease.
6.
The continuous cell-free protein synthesis method according to any one of claims 1 to 5, wherein the energy regeneration system enzyme is creatine kinase.
7.
The continuous cell-free protein synthesis method according to any one of claims 1 to 6, wherein the additional amount of the mRNA is 1/10 to the same as the amount of the raw material mRNA.
Claim 8.
The continuous cell-free protein synthesis method according to any one of claims 1 to 7, wherein the additional amount of the energy regenerating system enzyme is 1/10 to the same as the amount of the raw material energy regenerating system enzyme.
9.
The continuous cell-free protein synthesis method according to any one of claims 1 to 8, wherein the additional addition of mRNA and the additional addition of the energy regeneration system enzyme are continuously performed.
10.
The continuous cell-free protein synthesis method according to any one of claims 1 to 9, further comprising a step of preventing a substrate and an energy source from being depleted and / or a step of discharging a by-product.
11.
11. The continuous cell-free protein synthesis method according to claim 10, wherein the step is exchange of a dialysate.
12.
The continuous cell-free protein synthesis method according to any one of claims 1 to 11, wherein a treatment selected from addition, storage, exchange, and discharge is automatically controlled.
Claim 13
A continuous cell-free protein synthesis apparatus capable of executing the continuous cell-free protein synthesis method according to claim 1.
14.
A reagent kit used in the continuous cell-free protein synthesis method according to any one of claims 1 to 12.
15.
A continuous cell-free protein synthesis device that can introduce treatments selected from addition, storage, exchange, and discharge for elements selected from mRNA, energy-regenerating enzymes, substrates, and energy sources that serve as templates for synthesis reactions. And a lid that is sealably attached to the apparatus. The apparatus has a flow having an inlet that is a means for introducing a substrate and / or an energy source and an outlet that is connected to a liquid chamber in an impregnation tank for an external dialysis solution. Channel, a channel having an inlet in the liquid chamber in the impregnation tank, which is a means for discharging metabolites and the like in the dialysis external solution, and a channel having an outlet connected to the outside; A device for supporting a medium having the function of a dialysis membrane in a liquid chamber in an external liquid impregnation tank.

JP11151599A 1999-05-11 1999-05-31 Means for synthesizing continuous cell-free protein Pending JP2000333673A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP11151599A JP2000333673A (en) 1999-05-31 1999-05-31 Means for synthesizing continuous cell-free protein
CA002373057A CA2373057A1 (en) 1999-05-11 1999-07-29 Preparation containing cell extracts for cell-free protein synthesis and means for synthesizing protein using the preparation
US10/019,995 US6905843B1 (en) 1999-05-11 1999-07-29 Preparation containing cell extracts for synthesizing cell-free protein and means for synthesizing cell-free protein
DE69940525T DE69940525D1 (en) 1999-05-11 1999-07-29 PREPARATIONS CONTAINING A ZELEXTRACT FOR THE PRODUCTION OF A CELL-FREE PROTEIN AND DEVICE FOR PRODUCING A CELL-FREE PROTEIN
AT99933168T ATE424467T1 (en) 1999-05-11 1999-07-29 PREPARATION CONTAINING A CELL EXTRACT FOR PRODUCING A CELL-FREE PROTEIN AND DEVICE FOR PRODUCING A CELL-FREE PROTEIN
KR1020017014336A KR100546009B1 (en) 1999-05-11 1999-07-29 Preparation containing cell extracts for cell-free protein synthesis and means for synthesizing cell-free protein
EP99933168A EP1176210B1 (en) 1999-05-11 1999-07-29 Preparation containing cell extract for synthesizing cell-free protein and means for synthesizing cell-free protein
PCT/JP1999/004088 WO2000068412A1 (en) 1999-05-11 1999-07-29 Preparation containing cell extract for synthesizing cell-free protein and means for synthesizing cell-free protein
EA200101189A EA006162B1 (en) 1999-05-11 1999-07-29 Preparation for synthesizing cell-free protein, method for synthesizing protein using said preparation and apparatus therefor
AU49301/99A AU765632B2 (en) 1999-05-11 1999-07-29 Preparation containing cell extract for synthesizing cell-free protein and means for synthesizing cell-free protein
US11/089,652 US7235382B2 (en) 1999-05-11 2005-03-25 Preparation containing cell extracts for cell-free protein synthesis and means for synthesizing protein using the preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11151599A JP2000333673A (en) 1999-05-31 1999-05-31 Means for synthesizing continuous cell-free protein

Publications (2)

Publication Number Publication Date
JP2000333673A JP2000333673A (en) 2000-12-05
JP2000333673A5 true JP2000333673A5 (en) 2006-07-13

Family

ID=15522059

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11151599A Pending JP2000333673A (en) 1999-05-11 1999-05-31 Means for synthesizing continuous cell-free protein

Country Status (1)

Country Link
JP (1) JP2000333673A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2385134A1 (en) * 1999-10-15 2001-04-19 Wakenyaku Co., Ltd. Template molecule having broad applicability and highly efficient function means of cell-free synthesis of proteins by using the same
EP2311953A1 (en) 2004-08-04 2011-04-20 Riken Bone/joint disease susceptibility gene and use thereof
JP4513495B2 (en) * 2004-10-15 2010-07-28 株式会社島津製作所 Cell-free protein synthesis method using insect cell-derived extract
EP1997902B1 (en) 2006-03-30 2013-09-18 Hiroshima University Screening method
JPWO2007119623A1 (en) 2006-03-31 2009-08-27 独立行政法人理化学研究所 Novel use of G protein-coupled receptor and its ligand
US20100112601A1 (en) 2006-08-08 2010-05-06 Kyoto University Novel monoclonal antibody and use of the same
US8394615B2 (en) 2008-01-07 2013-03-12 Toyo Boseki Kabushiki Kaisha Glucose dehydrogenase
JP5704722B2 (en) 2009-02-24 2015-04-22 国立大学法人 宮崎大学 Cell adhesion inhibitor and use thereof
JP6065587B2 (en) 2011-02-23 2017-01-25 東洋紡株式会社 Alkaline phosphatase
KR102284067B1 (en) * 2019-07-19 2021-07-30 충남대학교 산학협력단 Screening method based on cell-free protein synthesis to determine the factors affecting the expression efficiency or activity of recombinant proteins
JP7426764B1 (en) 2023-06-05 2024-02-02 NUProtein株式会社 Protein production methods, cultured meat production methods, additives used in cultured meat production methods, and kits used in protein production methods

Similar Documents

Publication Publication Date Title
JP2000333673A5 (en)
CA2369222A1 (en) Apparatus and methods for parallel processing of multiple reaction mixtures
DE50102717D1 (en) Supported metal membrane, process for its manufacture and use
WO2001043871A3 (en) Microarray hybridization chamber
ATE304358T1 (en) (S,S)-REBOXETINE FOR THE TREATMENT OF MIGRAINE HEADACHE
JP2003521877A5 (en)
GB0411381D0 (en) Assay method and apparatus
JPS6250113B2 (en)
AU2002351643A1 (en) Triphasic bioreactor and process for gas effluent treatment
CA2563841A1 (en) Use of porous membrane to support developing conifer somatic embryos
JP2020028245A5 (en)
DE60227335D1 (en) Continuous process for the modification of starch and starch derivatives by means of branching enzymes
WO2006097762A3 (en) Improvements in or relating to the regeneration of water treatment substrates
KR880700059A (en) Method and apparatus for catalyst inhibition in a multiphase membrane reactor system
JPS5835679B2 (en) Kosohannouno Jitsushihouhou
DK474582A (en) 6-FLUORO-3- (3- (1-HETEROCYCLO) PROPYL) -1,2-BENZISOXAZOLES, PROCEDURES FOR PREPARING IT, PHARMACEUTICAL PREPARATIONS THEREOF
JPS6327079B2 (en)
DE10347476A1 (en) Method for destroying cells in sewage sludge involves adding chemical which changes its pH under specific treatment conditions
DE50012526D1 (en) KIT FOR THE IMPROVEMENT OF BIOCHEMICAL REACTIONS WITH HIGH THROUGHPUT
CA2393016A1 (en) Triphasic bioreactor and process for gas effluent treatment
Reiken et al. The use of a single‐fiber reactor for the enzymatic removal of amino acids from solutions
JPS59162873A (en) Immobilized enzyme reactor
JP6970311B2 (en) Enzyme-porous carbon complex
JPH022342A (en) Method for culturing biological cell having ph regulating and ammonia removing function and apparatus therefor
JPH078077Y2 (en) Contact aeration tank